These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
364 related articles for article (PubMed ID: 33092505)
1. Differential Impacts of Azole Antifungal Drugs on the Pharmacokinetic Profiles of Dasatinib in Rats by LC-MS-MS. Luo X; Xue X; Li T; Zhang Y; Huang L; Cheng G Curr Drug Metab; 2020; 21(13):1022-1030. PubMed ID: 33092505 [TBL] [Abstract][Full Text] [Related]
2. Potential interactions between triazole antifungal agents and lorlatinib based on ultra-performance liquid chromatography-tandem mass spectrometry in rat plasma. Ye Z; Wang C; Li R; Chen C; Yang J; Chen Y; Fu J; Zhou T; Jin M; Huang A; Zhang X; Zhou Z J Pharm Pharmacol; 2024 Jan; 76(2):115-121. PubMed ID: 38150242 [TBL] [Abstract][Full Text] [Related]
3. Simultaneous determination of three tyrosine kinase inhibitors and three triazoles in human plasma by LC-MS/MS: applications to therapeutic drug monitoring and drug-drug interaction studies. Li N; Liu L; Liu D; Yu H; Yang G; Qiu L; Chen Y; Xiang D; Gong X J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Oct; 1246():124276. PubMed ID: 39208604 [TBL] [Abstract][Full Text] [Related]
4. Physiologically based pharmacokinetic modeling and simulation to predict drug-drug interactions of ivosidenib with CYP3A perpetrators in patients with acute myeloid leukemia. Prakash C; Fan B; Ke A; Le K; Yang H Cancer Chemother Pharmacol; 2020 Nov; 86(5):619-632. PubMed ID: 32978634 [TBL] [Abstract][Full Text] [Related]
5. Triazole Antifungal Quantification for Therapeutic Drug Monitoring in Serum by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS): Posaconazole, Voriconazole, Itraconazole, and Hydroxyitraconazole. Girton M; Tomsig J; Bazydlo L Methods Mol Biol; 2024; 2737():55-65. PubMed ID: 38036810 [TBL] [Abstract][Full Text] [Related]
6. Effects of the CYP3A inhibitors, voriconazole, itraconazole, and fluconazole on the pharmacokinetics of osimertinib in rats. Lou Y; Song F; Cheng M; Hu Y; Chai Y; Hu Q; Wang Q; Zhou H; Bao M; Gu J; Zhang Y PeerJ; 2023; 11():e15844. PubMed ID: 37581117 [TBL] [Abstract][Full Text] [Related]
7. Effects of oral posaconazole on the pharmacokinetic properties of oral and intravenous midazolam: a phase I, randomized, open-label, crossover study in healthy volunteers. Krishna G; Moton A; Ma L; Savant I; Martinho M; Seiberling M; McLeod J Clin Ther; 2009 Feb; 31(2):286-98. PubMed ID: 19302901 [TBL] [Abstract][Full Text] [Related]
8. Application of Physiologically Based Pharmacokinetic Modeling to the Understanding of Bosutinib Pharmacokinetics: Prediction of Drug-Drug and Drug-Disease Interactions. Ono C; Hsyu PH; Abbas R; Loi CM; Yamazaki S Drug Metab Dispos; 2017 Apr; 45(4):390-398. PubMed ID: 28167538 [TBL] [Abstract][Full Text] [Related]
9. Effects of CYP3A inhibitors on the pharmacokinetics of quizartinib, a potent and selective FLT3 inhibitor, and its active metabolite. Li J; Kankam M; Trone D; Gammon G Br J Clin Pharmacol; 2019 Sep; 85(9):2108-2117. PubMed ID: 31173645 [TBL] [Abstract][Full Text] [Related]
10. Effects of ketoconazole, voriconazole, and itraconazole on the pharmacokinetics of apatinib in rats. Lou D; Cui X; Bao SS; Sun W; Pan WH; Chen MC; Dong YY; Hu GX; Chen RJ; Wang Z Drug Dev Ind Pharm; 2019 Apr; 45(4):689-693. PubMed ID: 30632818 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic interaction study of combining imatinib with dasatinib in rats by UPLC-MS/MS. Zhou Y; Wang S; Ding T; Wu M; Geng P; Zhang Q; Ma J Drug Dev Ind Pharm; 2015; 41(12):1948-53. PubMed ID: 25632980 [TBL] [Abstract][Full Text] [Related]
12. Reliable and Easy-To-Use Liquid Chromatography-Tandem Mass Spectrometry Method for Simultaneous Analysis of Fluconazole, Isavuconazole, Itraconazole, Hydroxy-Itraconazole, Posaconazole, and Voriconazole in Human Plasma and Serum. Müller C; Gehlen D; Blaich C; Prozeller D; Liss B; Streichert T; Wiesen MHJ Ther Drug Monit; 2017 Oct; 39(5):505-513. PubMed ID: 28742650 [TBL] [Abstract][Full Text] [Related]
14. Simultaneous determination of voriconazole, posaconazole, itraconazole and hydroxy-itraconazole in human plasma using LCMS/MS. Jenkins N; Black M; Schneider HG Clin Biochem; 2018 Mar; 53():110-115. PubMed ID: 29325818 [TBL] [Abstract][Full Text] [Related]
15. Differential effects of ketoconazole, itraconazole and voriconazole on the pharmacokinetics of imatinib and its main metabolite GCP74588 in rat. Lin G; Wang C; Qiu X; Wang Z; Han A; Xu T; Kan X; Hu G Drug Dev Ind Pharm; 2014 Dec; 40(12):1616-22. PubMed ID: 24053419 [TBL] [Abstract][Full Text] [Related]
16. Leveraging Physiologically Based Pharmacokinetic Modeling and Experimental Data to Guide Dosing Modification of CYP3A-Mediated Drug-Drug Interactions in the Pediatric Population. Salerno SN; Carreño FO; Edginton AN; Cohen-Wolkowiez M; Gonzalez D Drug Metab Dispos; 2021 Sep; 49(9):844-855. PubMed ID: 34154994 [TBL] [Abstract][Full Text] [Related]
17. Development of a liquid chromatography tandem mass spectrometry method for the simultaneous measurement of voriconazole, posaconazole and itraconazole. Wadsworth JM; Milan AM; Anson J; Davison AS Ann Clin Biochem; 2017 Nov; 54(6):686-695. PubMed ID: 27941128 [TBL] [Abstract][Full Text] [Related]
18. Corneal Pharmacokinetics of Voriconazole and Posaconazole following Intrastromal Injection and Posaconazole Eye Drops Instillation in Rats. Gueudry J; Le Goff L; Lamoureux F; Pereira T; Levefre S; Razakandrainibe R; Costa D; Ballet JJ; Muraine M; Favennec L Curr Eye Res; 2020 Nov; 45(11):1369-1372. PubMed ID: 32228098 [No Abstract] [Full Text] [Related]
19. Development of UPLC-MS/MS Method for Studying the Pharmacokinetic Interaction Between Dasatinib and Posaconazole in Rats. Yang S; Zhang X; Wang Y; Wen C; Wang C; Zhou Z; Lin G Drug Des Devel Ther; 2021; 15():2171-2178. PubMed ID: 34079220 [TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of ketoconazole and voriconazole on the pharmacokinetics of carvedilol in rats. Wang L; Wang S; Chen M; Chen X; Lin Y; Hu X; Huang X; Li X; Hu G Drug Dev Ind Pharm; 2015; 41(10):1661-6. PubMed ID: 25417773 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]